Axsome to Present New Sunosi Data at SLEEP 2023

Axsome Therapeutics Inc will present new data on Sunosi (solriamfetol) at SLEEP 2023, including results from the SHARP study.

Related Keywords

United Kingdom ,Germany ,German ,Russell Rosenberg ,Hans Van Dongen ,Johannes Gutenberg ,Department Of Neurology ,Axsome Therapeutics Inc ,Neurotrials Research ,Professor At Washington State University ,Medicine Center ,Washington State University ,Drug Administration ,Cognitive Health ,Apnea Participants During ,Randomized Placebo Controlled ,Obstructive Sleep Apnea ,Excessive Daytime ,Washington State ,Board Number ,Follow Up Experience ,Yaroslav Winter ,Mainz Comprehensive Epilepsy ,Sleep Medicine Center ,Johannes Gutenberg University ,Excessive Sleepiness ,Effect Sizes ,Numbers Needed ,Healthcare Resource Utilization Burden ,Excessive Daytime Sleepiness ,Gregory Parks ,